http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/list Mynewsdesk nyhetsfeed direkt från källan http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/list http://www.mynewsdesk.com/images/redesign/graphics/logos/logo-small.png 128 23 sv 15 Tue, 01 Mar 2011 10:35:00 +0100 Ulf Skough har utsetts till ny VD för A+ Science Holding AB och tillträder den 1 mars med placering i Stockholm. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/ny-vd-utsedd-paa-a-science-602796?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/ny-vd-utsedd-paa-a-science-602796?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Fri, 17 Dec 2010 10:58:00 +0100 Agneta Franksson, former CEO of A + Science, has decided to resign. Håkan Gartell has been appointed acting CEO. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/haakan-gartell-appointed-acting-ceo-of-a-science-549818?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/haakan-gartell-appointed-acting-ceo-of-a-science-549818?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Thu, 16 Dec 2010 11:18:00 +0100 Agneta Franksson, VD i A+ Science Holding AB, har beslutat sig för att avgå. Hon kommer att avgå med omedelbar verkan. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-vd-i-a-science-holding-avgaar-545811?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-vd-i-a-science-holding-avgaar-545811?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Mon, 06 Dec 2010 16:25:00 +0100 Extra bolagsstämma i A+ Science Holding AB, 556652-6835, hölls i Stockholm måndagen den 6 december 2010. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-kommunike-fraan-extra-bolagsstaemma-i-a-science-holding-ab-537658?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-kommunike-fraan-extra-bolagsstaemma-i-a-science-holding-ab-537658?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Mon, 22 Nov 2010 10:18:00 +0100 Styrelsen i A+ Science Holding AB har beslutat att kalla aktieägarna i A+ Science Holding AB (publ), org. nr 556652-6835 ("Bolaget"), till extra bolagsstämma i Advokatfirman Lindahls lokaler, Mäster Samuelsgatan 20, Stockholm, måndagen den 6 december 2010 kl. 15.00. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-extra-bolagsstaemma-i-a-science-holding-ab-524951?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-extra-bolagsstaemma-i-a-science-holding-ab-524951?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Fri, 12 Nov 2010 17:06:00 +0100 Valberedningen i A+ Science Holding AB (publ) kommer vid en extra bolagsstämma att föreslå Akbar Seddigh som ny styrelseordförande. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-akbar-seddigh-foereslaas-som-ny-styrelseordfoerande-i-a-science-holding-ab-publ-518879?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-akbar-seddigh-foereslaas-som-ny-styrelseordfoerande-i-a-science-holding-ab-publ-518879?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Fri, 12 Nov 2010 16:09:00 +0100 A+ Science Holding AB:s styrelseordförande Åsa Rödén har meddelat att hon på grund av personliga skäl önskar lämna sitt uppdrag i bolaget. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-styrelseordfoerande-slutar-i-a-science-holding-ab-publ-518861?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/a-science-styrelseordfoerande-slutar-i-a-science-holding-ab-publ-518861?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Wed, 10 Nov 2010 14:45:00 +0100 - CRO-företagens orderböcker slutade fyllas på förra året A+ Science har haft ett tungt 2010 så här långt på grund av ett tungt marknadsläge. Företagets besparingsprogram gör dock att rörelseresultatet förbättras jämfört med förra året. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/nyheter-fraan-bequoted-a-science-kaenner-av-branschnedgaang-516625?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/nyheter-fraan-bequoted-a-science-kaenner-av-branschnedgaang-516625?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Mon, 30 Aug 2010 22:53:34 +0200 Positive results from the SHIFT trial were published in the Lancet online, August 29, 2010. With more than 6500 patients in 37 countries it is the largest heart failure trial published to date. Contract research Organization A+ Science managed the coordination of sites from start up to close-out in 6 European countries. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/shift-trial-presents-positive-results-460968?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/shift-trial-presents-positive-results-460968?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Fri, 20 Aug 2010 18:11:19 +0200 The appointment of Helena as MedTech Director is yet a step in an increased medical device focus at A+ Science. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/helena-fenger-krog-appointed-medtech-director-455523?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/helena-fenger-krog-appointed-medtech-director-455523?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Thu, 12 Aug 2010 11:33:27 +0200 Vita Nova Ventures har bytt namn till A+ Science Holding och samtidigt renodlat verksamheten. Nu satsar bolaget på kliniska prövningar inom medicinteknik. Marknaden anses intressant tack vare nya föreskrifter som stärker kraven på producenterna att testa sina produkter. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/bequoted-nyheter-a-science-satsar-stort-paa-medicinteknik-nytt-direktiv-skapar-ny-marknad-foer-cro-tjaenster-451199?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/bequoted-nyheter-a-science-satsar-stort-paa-medicinteknik-nytt-direktiv-skapar-ny-marknad-foer-cro-tjaenster-451199?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Fri, 19 Feb 2010 17:18:00 +0100 Med anledning av att det medicintekniska regelverket skärps den 21 mars 2010, inbjuder A+ Science till ett kortare seminarium. Vi hjälper er bemöta de nya kraven, främst inom klinisk utvärdering, samt ger tips och råd om vad ni behöver göra för att uppfylla de uppdaterade direktiven. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/hur-paaverkas-ni-naer-kravet-paa-klinisk-utvaerdering-skaerps-374866?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/hur-paaverkas-ni-naer-kravet-paa-klinisk-utvaerdering-skaerps-374866?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Tue, 01 Sep 2009 14:28:00 +0200 A+ Science Pharmacovigilance department launches 24 h MD services http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/pharmacovigilance-department-launches-24-h-md-services-314610?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/pharmacovigilance-department-launches-24-h-md-services-314610?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Fri, 29 May 2009 00:00:00 +0200 Patienter söks till en läkemedelsprövning av försöksläkemedlet Otelixizumab. Otelixizumab har i tidigare prövningar visat sig kunna bevara insulinproduktionen för patienter med tidig typ 1-diabetes i upp till 48 månader. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/nytt-foersoekslaekemedel-kan-hjaelpa-personer-med-typ-1-diabetes-att-producera-eget-insulin-298218?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/nytt-foersoekslaekemedel-kan-hjaelpa-personer-med-typ-1-diabetes-att-producera-eget-insulin-298218?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Tue, 19 May 2009 15:11:00 +0200 Agneta Franksson har utsetts till ny VD för A+ Science AB och tillträder den 25 maj med placering i Stockholm. Franksson kommer att ha stort fokus på sälj- och marknads bearbetning. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/ny-vd-foer-a+-science-296965?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/ny-vd-foer-a+-science-296965?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Tue, 19 May 2009 15:11:00 +0200 Agneta Franksson has been appointed Managing Director of A + Science AB, effective on May 25. Franksson will be located at the Stockholm office and will have a strong focus on sales and marketing. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/agneta-franksson-has-been-appointed-new-managing-director-296964?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/agneta-franksson-has-been-appointed-new-managing-director-296964?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Thu, 05 Feb 2009 10:20:00 +0100 Den 3 februari 2009 publicerades resultat från ALLAY-studien som visar att reninhämmaren Aliskiren är lika effektiv som Losartan i att reducera vänsterkammarhypertrofi. Uppföljningen efter 36 veckor visade att även blodtrycket sänktes lika effektivt. Aliskiren är det första oralt aktiva läkemedlet i den klass som kallas direkta reninhämmare. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/renin-haemmaren-aliskiren-lika-effektiv-som-losartan-vid-vaensterkammarhypertrofi-270067?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/renin-haemmaren-aliskiren-lika-effektiv-som-losartan-vid-vaensterkammarhypertrofi-270067?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Thu, 05 Feb 2009 10:20:00 +0100 Results of the ALLAY study, published in Circulation, shows that Aliskiren is as effective as Losartan in reducing LV mass. The follow-up (after 36 weeks) also showed that Aliskiren proved equally effective in lowering blood pressure. Aliskiren is the first orally active direct renin inhibitor. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/direct-renin-inhibitor-aliskiren-as-effective-as-losartan-269972?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/direct-renin-inhibitor-aliskiren-as-effective-as-losartan-269972?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Mon, 02 Feb 2009 15:00:00 +0100 Ulrika Stenson har utsetts till tillförordnad VD i A+ Science AB. Hon har sedan slutet av maj 2008 varit operativ chef. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/ledningsfoeraendring-274243?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/ledningsfoeraendring-274243?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science Tue, 27 Jan 2009 11:00:00 +0100 CAFE-LLA Studien undersökte huruvida Atorvastatin (10 mg/ en gång dagligen) påverkade centralt blodtryck i aorta på patienter med högt blodtryck. Resultatet visade att så inte var fallet. Det innebär att de fördelaktiga effekterna av statin på kardiovaskulära händelser är oberoende av centralt blodtryck och de stora blodkärlens funktionalitet. http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/cafe-lla-studien-presenterar-resultat-med-atorvastatin-behandling-267807?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease http://www.mynewsdesk.com/se/pressroom/a-science/pressrelease/view/cafe-lla-studien-presenterar-resultat-med-atorvastatin-behandling-267807?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=pressrelease A+ Science